Medartis Holding AG
Global provider of high-precision implants & instruments for surgical fracture fixation.
MED | SW
Overview
Corporate Details
- ISIN(s):
- CH0386200239
- LEI:
- 506700VUSP6HG3F28846
- Country:
- Switzerland
- Address:
- Hochbergerstr. 60E, 4057 Basel
- Website:
- https://www.medartis.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Medartis Holding AG is a global medical device company that develops, manufactures, and distributes high-precision implants and instruments for surgical fracture fixation. The company specializes in osteosynthesis solutions for the upper and lower extremities, as well as the craniomaxillofacial skeleton. Its product portfolio includes titanium screws, plates, and system solutions, marketed under brands like APTUS, MODUS, and StealthFix. Medartis serves surgeons, hospitals, and medical centers worldwide, emphasizing its Swiss engineering and manufacturing standards to provide advanced, best-in-class technology. In 2023, the company expanded its lower extremities portfolio through the acquisition of U.S.-based Nextremity Solutions Inc.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-24 06:59 |
Board/Management Information
Medartis appoints Peter Hackel as new Chief Financial Officer
|
English | 6.0 KB | ||
| 2025-11-24 01:00 |
Board/Management Information
Medartis appoints Peter Hackel as new Chief Financial Officer
|
English | 9.3 KB | ||
| 2025-11-24 01:00 |
Board/Management Information
Medartis ernennt Peter Hackel zum neuen Finanzchef
|
German | 10.2 KB | ||
| 2025-08-19 06:58 |
Earnings Release
Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for…
|
English | 58.8 KB | ||
| 2025-08-19 02:00 |
Earnings Release
Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for…
|
English | 65.2 KB | ||
| 2025-08-19 02:00 |
Earnings Release
Medartis erzielt im ersten Halbjahr ein organisches Umsatzwachstum von 15,3 % u…
|
German | 67.9 KB | ||
| 2025-07-30 09:59 |
Regulatory News Service
Medartis 2025 half-year results webcast
|
English | 11.1 KB | ||
| 2025-07-17 06:59 |
M&A Activity
Medartis acquires remaining 53% stake in KeriMedical
|
English | 11.8 KB | ||
| 2025-07-17 02:00 |
M&A Activity
Medartis acquires remaining 53% stake in KeriMedical
|
English | 15.5 KB | ||
| 2025-07-17 02:00 |
M&A Activity
Medartis erwirbt restliche 53 % der Anteile an KeriMedical
|
German | 16.3 KB | ||
| 2025-03-19 06:59 |
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
|
English | 54.2 KB | ||
| 2025-03-18 06:59 |
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
|
English | 54.2 KB | ||
| 2025-03-18 01:00 |
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
|
English | 61.8 KB | ||
| 2025-03-18 01:00 |
Earnings Release
Medartis erzielt 2024 ein Kernumsatzwachstum von 12 % und verbessert ihre Kern-…
|
German | 63.2 KB | ||
| 2024-08-20 07:05 |
Earnings Release
Medartis reports 13% revenue growth on Group level, driven by strong regional g…
|
English | 51.0 KB |
Automate Your Workflow. Get a real-time feed of all Medartis Holding AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Medartis Holding AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Medartis Holding AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-04-21 | N/A | Executive member | Sell | None | 84,693.20 CHF |
| 2022-04-14 | N/A | Non-Executive member | Buy | None | 35,691.00 CHF |
| 2022-04-11 | N/A | Non-Executive member | Buy | None | 49,928.35 CHF |
| 2022-04-11 | N/A | Non-Executive member | Buy | None | 99,964.75 CHF |
| 2022-04-11 | N/A | Non-Executive member | Buy | None | 124,928.90 CHF |
| 2022-04-11 | N/A | Non-Executive member | Buy | None | 248,639.20 CHF |
| 2022-04-11 | N/A | Non-Executive member | Buy | None | 37,500.30 CHF |
| 2022-04-08 | N/A | Executive member | Buy | None | 70,082.25 CHF |
| 2022-04-08 | N/A | Executive member | Buy | None | 58,735.60 CHF |
| 2022-04-08 | N/A | Executive member | Buy | None | 375,011.55 CHF |
Peer Companies
